Role of calcium-sensing receptor in mineral ion metabolism and inherited disorders of calcium-sensing

Okabe, 2004, The origin of the parathyroid gland, Proc. Natl. Acad. Sci. USA, 101, 17716, 10.1073/pnas.0406116101 Brown, 1991, Extracellular Ca2+ sensing, regulation of parathyroid cell function, and role of Ca2+ and other ions as extracellular (first) messengers, Physiol. Rev., 71, 371, 10.1152/physrev.1991.71.2.371 Bringhurst, 1998, Hormones and disorders of mineral metabolism, 1155 Brown, 1983, Four-parameter model of the sigmoidal relationship between parathyroid hormone release and extracellular calcium concentration in normal and abnormal parathyroid tissue, J. Clin. Endocrinol. Metab., 56, 572, 10.1210/jcem-56-3-572 Brown, 1993, Cloning and characterization of an extracellular Ca2+-sensing receptor from bovine parathyroid, Nature, 366, 575, 10.1038/366575a0 Garrett, 1995, Molecular cloning and functional expression of human parathyroid calcium receptor cDNAs, J. Biol. Chem., 270, 2919, 10.1074/jbc.270.21.12919 Aida, 1995, Molecular cloning of a putative Ca2+-sensing receptor cDNA from human kidney, Biochem. Biophys. Res. Commun., 214, 524, 10.1006/bbrc.1995.2318 Riccardi, 1995, Cloning and functional expression of a rat kidney extracellular calcium/polyvalent cation-sensing receptor, Proc. Natl. Acad. Sci. USA, 92, 131, 10.1073/pnas.92.1.131 Butters, 1997, Cloning and characterization of a calcium-sensing receptor from the hypercalcemic New Zealand white rabbit reveals unaltered responsiveness to extracellular calcium, J. Bone Miner. Res., 12, 568, 10.1359/jbmr.1997.12.4.568 Garrett, 1995, Calcitonin-secreting cells of the thyroid express an extracellular calcium receptor gene, Endocrinology, 136, 5202, 10.1210/en.136.11.5202 Ruat, 1995, Calcium sensing receptor: molecular cloning from rat striatal library and localization to nerve terminals, Proc. Natl. Acad. Sci. USA, 92, 3161, 10.1073/pnas.92.8.3161 Brown, 2001, Extracellular calcium sensing and extracellular calcium signaling, Physiol. Rev., 81, 239, 10.1152/physrev.2001.81.1.239 Felder, 1999, The Venus flytrap of periplasmic binding proteins: an ancient protein module present in multiple drug receptors, AAPS Pharm. Sci., 1, E2, 10.1208/ps010202 Oh, 1993, Three-dimensional structures of the periplasmic lysine/arginine/ornithine-binding protein with and without a ligand, J. Biol. Chem., 268, 11348, 10.1016/S0021-9258(18)82131-7 Bai, 1998, Dimerization of the extracellular calcium-sensing receptor (CaR) on the cell surface of CaR-transfected HEK293 cells, J. Biol. Chem., 273, 23605, 10.1074/jbc.273.36.23605 Ray, 1999, Identification of the cysteine residues in the amino-terminal extracellular domain of the human Ca2+ receptor critical for dimerization. Implications for function of monomeric Ca2+ receptor, J. Biol. Chem., 274, 27642, 10.1074/jbc.274.39.27642 Hu, 2003, Naturally occurring mutations of the extracellular Ca2+-sensing receptor: implications for its structure and function, Trends Endocrinol. Metab., 14, 282, 10.1016/S1043-2760(03)00104-8 Silve, 2005, Delineating a Ca2+ binding pocket within the venus flytrap module of the human calcium-sensing receptor, J. Biol. Chem., 280, 37917, 10.1074/jbc.M506263200 Conigrave, 2000, l-amino acid sensing by the extracellular Ca2+-sensing receptor, Proc. Natl. Acad. Sci. USA, 97, 4814, 10.1073/pnas.97.9.4814 Zhang, 2002, l-Phenylalanine and NPS R-467 synergistically potentiate the function of the extracellular calcium-sensing receptor through distinct sites, J. Biol. Chem., 277, 33736, 10.1074/jbc.M200978200 Ray, 2002, Evidence for distinct cation and calcimimetic compound (NPS 568) recognition domains in the transmembrane regions of the human Ca2+ receptor, J. Biol. Chem., 277, 18908, 10.1074/jbc.M202113200 Bai, 1998, Protein kinase C phosphorylation of threonine at position 888 in Ca2+o-sensing receptor (CaR) inhibits coupling to Ca2+ store release, J. Biol. Chem., 273, 21267, 10.1074/jbc.273.33.21267 Kifor, 1997, The Ca2+-sensing receptor (CaR) activates phospholipases C, A2, and D in bovine parathyroid and CaR-transfected, human embryonic kidney (HEK293) cells, J. Bone Miner. Res., 715, 10.1359/jbmr.1997.12.5.715 Hjalm, 2001, Filamin-A binds to the carboxyl-terminal tail of the calcium-sensing receptor, an interaction that participates in CaR-mediated activation of mitogen-activated protein kinase, J. Biol. Chem., 276, 34880, 10.1074/jbc.M100784200 Awata, 2001, Interaction of the calcium-sensing receptor and filamin, a potential scaffolding protein, J. Biol. Chem., 276, 34871, 10.1074/jbc.M100775200 Kifor, 1998, The calcium-sensing receptor is localized in caveolin-rich plasma membrane domains of bovine parathyroid cells, J. Biol. Chem., 273, 21708, 10.1074/jbc.273.34.21708 Zhang, 2005, High affinity interaction with filamin A protects against calcium-sensing receptor degradation, J. Biol. Chem., 280, 11140, 10.1074/jbc.M412242200 Pi, 2005, Identification of a novel extracellular cation-sensing G-protein-coupled receptor, J. Biol. Chem., 280, 40201, 10.1074/jbc.M505186200 Conigrave, 2000, Cooperative multi-modal sensing and therapeutic implications of the extracellular Ca2+-sensing receptor, Trends Pharmacol. Sci., 21, 401, 10.1016/S0165-6147(00)01546-7 Quinn, 1998, Sodium and ionic strength sensing by the calcium receptor, J. Biol. Chem., 273, 19579, 10.1074/jbc.273.31.19579 Quinn, 1998, The Ca2+-sensing receptor: a target for polyamines, Am. J. Physiol., 273, C1315, 10.1152/ajpcell.1997.273.4.C1315 Ye, 1997, Amyloid-beta proteins activate Ca2+-permeable channels through calcium-sensing receptors, J. Neurosci. Res., 47, 547, 10.1002/(SICI)1097-4547(19970301)47:5<547::AID-JNR10>3.0.CO;2-V Miki, 1997, Effect of magnesium on parathyroid cells: evidence for two sensing receptors or two intracellular pathways?, Am. J. Physiol., 272, E1 Handlogten, 2000, Extracellular Ca2+-sensing receptor is a promiscuous divalent cation sensor that responds to lead, Am. J. Physiol. Renal Physiol., 279, F1083, 10.1152/ajprenal.2000.279.6.F1083 Brown, 1990, A comparison of the effects of divalent and trivalent cations on parathyroid hormone release, 3′,5′-cyclic-adenosine monophosphate accumulation, and the levels of inositol phosphates in bovine parathyroid cells, Endocrinology, 127, 1064, 10.1210/endo-127-3-1064 Marie, 2006, Strontium ranelate: a dual mode of action rebalancing bone turnover in favour of bone formation, Curr. Opin. Rheumatol., 18, S11, 10.1097/01.bor.0000229522.89546.7b Coulombe, 2004, In vitro effects of strontium ranelate on the extracellular calcium-sensing receptor, Biochem. Biophys. Res. Commun., 323, 1184, 10.1016/j.bbrc.2004.08.209 Pi, 2004, A novel cation-sensing mechanism in osteoblasts is a molecular target for strontium, J. Bone Miner. Res., 19, 862, 10.1359/jbmr.040114 Nearing, 2002, Polyvalent cation receptor proteins (CaRs) are salinity sensors in fish, Proc. Natl. Acad. Sci. USA, 99, 9231, 10.1073/pnas.152294399 Flanagan, 2002, Cloning of the cDNA for the putative calcium-sensing receptor and its tissue distribution in sea bream (Sparus aurata), Gen. Comp. Endocrinol., 127, 117, 10.1016/S0016-6480(02)00035-7 Quinn, 2004, pH Sensing by the calcium-sensing receptor, J. Biol. Chem., 279, 37241, 10.1074/jbc.M404520200 Nemeth, 1998, Calcimimetics with potent and selective activity on the parathyroid calcium receptor, Proc. Natl. Acad. Sci. USA, 95, 4040, 10.1073/pnas.95.7.4040 Hammerland, 1996, NPS R-467 activation of chimeric calcium-metabotropic glutamate receptor and a calcium receptor deletion mutant indicates a site of action within the transmembrane domain of the calcium receptor, J. Bone Miner. Res., 11, S158 Miedlich, 2004, Homology modeling of the transmembrane domain of the human calcium sensing receptor and localization of an allosteric binding site, J. Biol. Chem., 279, 7254, 10.1074/jbc.M307191200 Petrel, 2004, Positive and negative allosteric modulators of the Ca2+-sensing receptor interact within overlapping but not identical binding sites in the transmembrane domain, J. Biol. Chem., 279, 18990, 10.1074/jbc.M400724200 Nemeth, 2002, Pharmacological regulation of parathyroid hormone secretion, Curr. Pharm. Des., 8, 2077, 10.2174/1381612023393387 Gowen, 2000, Antagonizing the parathyroid calcium receptor stimulates parathyroid hormone secretion and bone formation in osteopenic rats, J. Clin. Invest., 105, 1595, 10.1172/JCI9038 Conigrave, 2000, l-Amino acid sensing by the extracellular Ca2+-sensing receptor, Proc. Natl. Acad. Sci. USA, 97, 4814, 10.1073/pnas.97.9.4814 Conigrave, 2004, l-Amino acids regulate parathyroid hormone secretion, J. Biol. Chem., 279, 38151, 10.1074/jbc.M406373200 Mun, 2004, The Venus Fly Trap domain of the extracellular Ca2+-sensing receptor is required for l-amino acid sensing, J. Biol. Chem., 279, 51739, 10.1074/jbc.M406164/200 Mun, 2005, A double mutation in the extracellular Ca2+-sensing receptor’s venus flytrap domain that selectively disables l-amino acid sensing, J. Biol. Chem., 280, 29067, 10.1074/jbc.M500002200 Freichel, 1996, Expression of a calcium-sensing receptor in a human medullary thyroid carcinoma cell line and its contribution to calcitonin secretion, Endocrinology, 137, 3842, 10.1210/en.137.9.3842 Riccardi, 1996, Localization of the extracellular Ca2+-sensing receptor and PTH/PTHrP receptor in rat kidney, Am. J. Physiol., 271, F951 Riccardi, 1998, Localization of the extracellular Ca2+/polyvalent cation-sensing protein in rat kidney, Am. J. Physiol., 274, F611 Chattopadhyay, 1996, Ontogeny of the extracellular calcium-sensing receptor in rat kidney, Am. J. Physiol., 271, F736 Sands, 1997, Apical extracellular calcium/polyvalent cation-sensing receptor regulates vasopressin-elicited water permeability in rat kidney inner medullary collecting duct, J. Clin. Invest., 99, 1399, 10.1172/JCI119299 Gillin, 1993, Osmolarity-stimulated urea transport in rat terminal IMCD: role of intracellular calcium, Am. J. Physiol., 265, F272 Dvorak, 2004, Ca2+ as an extracellular signal in bone, Cell Calcium, 35, 249, 10.1016/j.ceca.2003.10.014 Gama, 1997, Ca2+-sensing receptors in intestinal epithelium, Am. J. Physiol., 273, C1168, 10.1152/ajpcell.1997.273.4.C1168 Chattopadhyay, 1998, Identification and localization of extracellular Ca(2+)-sensing receptor in rat intestine, Am. J. Physiol., 274, G122 Ba, 2003, Calcium-sensing receptor regulation of PTH-inhibitable proximal tubule phosphate transport, Am. J. Physiol. Renal Physiol., 285, F1233, 10.1152/ajprenal.00249.2003 Hebert, 1997, Role of the Ca2+-sensing receptor in divalent mineral ion homeostasis, J. Exp. Biol., 200, 295, 10.1242/jeb.200.2.295 Rogers, 1997, Localization of calcium receptor mRNA in the adult rat central nervous system by in situ hybridization, Brain Res., 744, 47, 10.1016/S0006-8993(96)01070-0 Washburn, 1999, Control of neuronal excitability by an ion-sensing receptor (correction of anion-sensing), Eur. J. Neurosci., 11, 1947, 10.1046/j.1460-9568.1999.00619.x Hoenderop, 2005, Calcium absorption across epithelia, Physiol. Rev., 85, 373, 10.1152/physrev.00003.2004 Mupanomunda, 1999, Interstitial Ca2+ undergoes dynamic changes sufficient to stimulate nerve-dependent Ca2+-induced relaxation, Am. J. Physiol., 276, H1035 Yamaguchi, 2003, Cacium-sensing receptor in bone, 103 Takahashi, 2002, High extracellular calcium affects osteoclastogenesis in mouse bone marrow cell culture, J. Med. Dent. Sci., 49, 109 Kanatani, 1999, High extracellular calcium inhibits osteoclast-like cell formation by directly acting on the calcium-sensing receptor existing in osteoclast precursor cells, Biochem. Biophys. Res. Commun., 261, 144, 10.1006/bbrc.1999.0932 Kaji, 1996, High extracellular calcium stimulates osteoclast-like cell formation and bone-resorbing activity in the presence of osteoblastic cells, J. Bone Miner. Res., 11, 912, 10.1002/jbmr.5650110707 Pollak, 1993, Mutations in the human Ca2+-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism, Cell, 757, 1297, 10.1016/0092-8674(93)90617-Y Brown, 2000, Familial hypocalciuric hypercalcemia and other disorders with resistance to extracellular calcium, Endocrinol. Metab. Clin. North Am., 29, 503, 10.1016/S0889-8529(05)70148-1 Foley, 1972, Familial benign hypercalcemia, J. Pediatr, 81, 1060, 10.1016/S0022-3476(72)80232-4 Marx, 1985, Familial hypocalciuric hypercalcemia. Mild expression of the gene in heterozygotes and severe expression in homozygotes, Am. J. Med., 78, 15, 10.1016/0002-9343(85)90455-3 Marx, 1981, The hypocalciuric or benign variant of familial hypercalcemia: clinical and biochemical features in fifteen kindreds, Medicine (Baltimore), 60, 397, 10.1097/00005792-198111000-00002 Chou, 1992, The gene responsible for familial hypocalciuric hypercalcemia maps to chromosome 3q in four unrelated families, Nat. Genet., 1, 295, 10.1038/ng0792-295 Heath, 1993, Genetic linkage analysis in familial benign (hypocalciuric) hypercalcemia: evidence for locus heterogeneity, Am. J. Hum. Genet., 53, 193 Trump, 1995, Linkage studies in a kindred from Oklahoma, with familial benign (hypocalciuric) hypercalcaemia (FBH) and developmental elevations in serum parathyroid hormone levels, indicate a third locus for FBH, Hum. Genet., 96, 183, 10.1007/BF00207376 Lloyd, 1999, Localization of familial benign hypercalcemia, Oklahoma variant (FBHOk), to chromosome 19q13, Am. J. Hum. Genet., 64, 189, 10.1086/302202 Auwerx, 1984, Altered parathyroid set point to calcium in familial hypocalciuric hypercalcemia, Acta Endocrinol., 106, 215, 10.1530/acta.0.1060215 Bai, 1997, Markedly reduced activity of mutant calcium-sensing receptor with an inserted Alu element from a kindred with familial hypocalciuric hypercalcemia and neonatal severe hyperpara-thyroidism, J. Clin. Invest., 99, 1917, 10.1172/JCI119359 Bai, 1996, Expression and characterization of inactivating and activating mutations in the human Ca2+ -sensing receptor, J. Biol. Chem., 271, 19537, 10.1074/jbc.271.32.19537 Bai, 1997, In vivo and in vitro characterization of neonatal hyperparathyroidism resulting from a de novo, heterozygous mutation in the Ca2+-sensing receptor gene: normal maternal calcium homeostasis as a cause of secondary hyperparathyroidism in familial benign hypocalciuric hypercalcemia, J. Clin. Invest., 99, 88, 10.1172/JCI119137 Pearce, 1996, Functional characterization of calcium-sensing receptor mutations expressed in human embryonic kidney cells, J. Clin. Invest., 98, 1860, 10.1172/JCI118987 Bai, 1999, Intermolecular interactions between dimeric calcium-sensing receptor monomers are important for its normal function, Proc. Natl. Acad. Sci. USA, 96, 2834, 10.1073/pnas.96.6.2834 Scillitani, 2004, Blood ionized calcium is associated with clustered polymorphisms in the carboxyl-terminal tail of the calcium-sensing receptor, J. Clin. Endocrinol. Metab., 89, 5634, 10.1210/jc.2004-0129 Pasieka, 1990, Familial benign hypercalcemia: hypercalciuria and hypcalciuria in affected members of a small kindered, Clin. Endocrinol., 33, 429, 10.1111/j.1365-2265.1990.tb03881.x Carling, 2000, Familial hypercalcemia and hypercalciuria caused by a novel mutation in the cytoplasmic tail of the calcium receptor, J. Clin. Endocrinol. Metab., 85, 2042, 10.1210/jc.85.5.2042 Pratt, 1947, Hypercalcemia and idiopathic hyperplasia of the parathyroid glands in an infant, J. Pediatr., 30, 388, 10.1016/S0022-3476(47)80079-4 Hillman, 1964, Neonatal familial hyperparathyroidism, N. Engl. J. Med., 270, 483, 10.1056/NEJM196403052701001 Gaudelus, 1983, Rib cage deformity in neonatal hyperparathyroidism, Am. J. Dis. Child., 137, 408 Heath, 1994, Familial hypocalciuric hypercalcemia, 699 Pearce, 1999, Casting new light on the clinical spectrum of neonatal severe hyperparathyroidism, Clin. Endocrinol. (Oxf), 50, 691, 10.1046/j.1365-2265.1999.00788.x Marx, 1986, Secretory dysfunction in parathyroid cells from a neonate with severe primary hyperparathyroidism, J. Clin. Endocrinol. Metab., 62, 445, 10.1210/jcem-62-2-445 Waller, 2004, Neonatal severe hyperparathyroidism: genotype/phenotype correlation and the use of pamidronate as rescue therapy, Eur. J. Pediatr., 163, 589, 10.1007/s00431-004-1491-0 Zhang, 2002, Three adjacent serines in the extracellular domains of the CaR are required for l-amino acid-mediated potentiation of receptor function, J. Biol. Chem., 277, 33727, 10.1074/jbc.M200976200 Pollak, 1994, Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Effects of mutant gene dosage on phenotype, J. Clin. Invest., 93, 1108, 10.1172/JCI117062 Pollak, 1994, Autosomal dominant hypocalcaemia caused by a Ca(2+)-sensing receptor gene mutation, Nat. Genet., 8, 303, 10.1038/ng1194-303 Lienhardt, 2000, A large homozygous or heterozygous in-frame deletion within the calcium-sensing receptor’s carboxylterminal cytoplasmic tail that causes autosomal dominant hypocalcemia, J. Clin. Endocrinol. Metab., 85, 1695, 10.1210/jc.85.4.1695 Watanabe, 2002, Association between activating mutations of calcium-sensing receptor and Bartter’s syndrome, Lancet, 360, 692, 10.1016/S0140-6736(02)09842-2 Vargas-Poussou, 2002, Antignac C Functional characterization of a calcium-sensing receptor mutation in severe autosomal dominant hypocalcemia with a Bartter-like syndrome, J. Am. Soc. Nephrol., 13, 2259, 10.1097/01.ASN.0000025781.16723.68 Hebert, 2003, Bartter syndrome, Curr. Opin. Nephrol. Hypertens., 12, 527, 10.1097/00041552-200309000-00008 Zhao, 1999, A missense mutation in the seventh transmembrane domain constitutively activates the human Ca2+ receptor, FEBS Lett., 448, 180, 10.1016/S0014-5793(99)00368-3 De Luca, 1997, Sporadic hypoparathyroidism caused by de Novo gain-of-function mutations of the Ca2+-sensing receptor, J. Clin. Endocrinol. Metab., 82, 2710, 10.1210/jc.82.8.2710 Blizzard, 1967, The incidence of adrenal and other antibodies in the sera of patients with idiopathic adrenal insufficiency (Addison’s disease), Clin. Exp. Immunol., 2, 19 Posillico, 1986, Parathyroid cell surface autoantibodies that inhibit parathyroid hormone secretion from dispersed human parathyroid cells, J. Bone Miner. Res., 1, 475, 10.1002/jbmr.5650010512 Li, 1996, Autoantibodies to the extracellular domain of the calcium sensing receptor in patients with acquired hypoparathyroidism, Clin. Invest., 97, 910, 10.1172/JCI118513 Kifor, 2004, Activating antibodies to the calcium-sensing receptor in two patients with autoimmune hypoparathyroidism, J. Clin. Endocrinol. Metab., 89, 548, 10.1210/jc.2003-031054 Kifor, 2003, A syndrome of hypocalciuric hypercalcemia caused by autoantibodies directed at the calcium-sensing receptor, J. Clin. Endocrinol. Metab., 88, 60, 10.1210/jc.2002-020249 Ho, 1995, A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism, Nat. Genet., 11, 389, 10.1038/ng1295-389 Kos, 2003, The calcium-sensing receptor is required for normal calcium homeostasis independent of parathyroid hormone, J. Clin. Invest., 111, 1021, 10.1172/JCI17416 Tu, 2003, Rescue of the skeletal phenotype in CasR-deficient mice by transfer onto the Gcm2 null background, J. Clin. Invest., 111, 1029, 10.1172/JCI200317054 Kifor, 1996, Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism, J. Clin. Endocrinol. Metab., 81, 1598, 10.1210/jc.81.4.1598 Gogusev, 1997, Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism, Kidney Int., 51, 328, 10.1038/ki.1997.41 Mathias, 1998, Reduced expression of the renal calcium-sensing receptor in rats with experimental chronic renal insufficiency, J. Am. Soc. Nephrol., 9, 2067, 10.1681/ASN.V9112067 Ritter, 2001, Parathyroid hyperplasia in uremic rats precedes down-regulation of the calcium receptor, Kidney Int., 60, 1737, 10.1046/j.1523-1755.2001.00027.x Rodriguez, 2005, The calcium-sensing receptor: a key factor in the pathogenesis of secondary hyperparathyroidism, Am. J. Physiol. Renal Physiol., 288, F253, 10.1152/ajprenal.00302.2004 Brown, 1996, Rat calcium-sensing receptor is regulated by vitamin D but not by calcium, Am. J. Physiol., 270, F454 Nemeth, 2001, Calcilytic compounds: potent and selective Ca2+ receptor antagonists that stimulate secretion of parathyroid hormone, J. Pharmacol. Exp. Ther., 299, 323 Silverberg, 1997, Short-term inhibition of parathyroid hormone secretion by a calcium-receptor agonist in patients with primary hyperparathyroidism, N. Engl. J. Med., 337, 1506, 10.1056/NEJM199711203372104 Shoback, 2003, The calcimimetic cinacalcet normalizes serum calcium in subjects with primary hyperparathyroidism, J. Clin. Endocrinol. Metab., 88, 5644, 10.1210/jc.2002-021597 Peacock, 2005, Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism, J. Clin. Endocrinol. Metab., 90, 135, 10.1210/jc.2004-0842 Ogata, 2003, Beneficial effects of calcimimetics on progression of renal failure and cardiovascular risk factors, J. Am. Soc. Nephrol., 14, 959, 10.1097/01.ASN.0000056188.23717.E5 Wada, 1997, The calcimimetic compound NPS R-568 suppresses parathyroid cell proliferation in rats with renal insufficiency, J. Clin. Invest., 100, 2977, 10.1172/JCI119851 Roussanne, 2001, Human parathyroid cell proliferation in response to calcium, NPS R-467, calcitriol and phosphate, Eur. J. Clin. Invest., 31, 610, 10.1046/j.1365-2362.2001.00809.x Wada, 1998, NPS R-568 halts or reverses osteitis fibrosa in uremic rats, Kidney Int., 53, 448, 10.1046/j.1523-1755.1998.00782.x Wada, 2000, Calcimimetic NPS R-568 prevents parathyroid hyperplasia in rats with severe secondary hyperparathyroidism, Kidney Int., 57, 50, 10.1046/j.1523-1755.2000.00837.x Fox, 1999, NPS R-568: a type II calcimimetic compound that acts on parathyroid cell calcium receptor of rats to reduce plasma levels of parathyroid hormone and calcium, J. Pharmacol. Exp. Ther., 290, 473 Silver, 1996, New insights into the regulation of parathyroid hormone synthesis and secretion in chronic renal failure, Nephrol. Dial. Transplant., 11, 2, 10.1093/ndt/11.supp3.2 Sudhaker Rao, 2000, Reduced vitamin D receptor expression in parathyroid adenomas: implications for pathogenesis, Clin. Endocrinol. (Oxf), 53, 373, 10.1046/j.1365-2265.2000.01081.x Yano, 2000, Association of decreased calcium-sensing receptor expression with proliferation of parathyroid cells in secondary hyperparathyroidism, Kidney Int., 58, 1980, 10.1111/j.1523-1755.2000.00370.x Block, 2004, Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis, N. Engl. J. Med., 350, 1516, 10.1056/NEJMoa031633 Antonsen, 1998, A calcimimetic agent acutely suppresses parathyroid hormone levels in patients with chronic renal failure, Kidney Int., 53, 223, 10.1046/j.1523-1755.1998.00735.x Goodman, 2000, A agent lowers plasma parathyroid hormone levels in patients with secondary hyperparathyroidism, Kidney Int., 58, 436, 10.1046/j.1523-1755.2000.00183.x Goodman, 2002, The calcimimetic agent AMG 073 lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidism, J. Am. Soc. Nephrol., 13, 1017, 10.1681/ASN.V1341017 Lindberg, 2003, The calcimimetic AMG 073 reduces parathyroid hormone and calcium×phosphorus in secondary hyperparathyroidism, Kidney Int., 63, 248, 10.1046/j.1523-1755.2003.00720.x Ohashi, 2004, The calcimimetic agent KRN 1493 lowers plasma parathyroid hormone and ionized calcium concentrations in patients with chronic renal failure on haemodialysis both on the day of haemodialysis and on the day without haemodialysis, Br. J. Clin. Pharmacol., 57, 726, 10.1111/j.1365-2125.2004.02088.x